Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Günter Kaufmann is active.

Publication


Featured researches published by Günter Kaufmann.


Steroids | 2003

The significance of the 20-carbonyl group of progesterone in steroid receptor binding: a molecular dynamics and structure-based ligand design study

Alexander Hillisch; Johannes von Langen; Bernd Menzenbach; Peter Droescher; Günter Kaufmann; Birgitt Schneider; Walter Elger

Polar functional groups in the A- and D-ring (positions 3 and 17beta or 20) are common to all natural and synthetic steroid hormones. It was assumed that these pharmacophoric groups are involved in strong hydrogen bonding interactions with the respective steroid receptors. High resolution X-ray structures of the estrogen and androgen receptors have confirmed these assumptions. Also site-directed mutagenesis studies of the human progesterone receptor (hPR) suggest an important role for Cys891 in the recognition of the progesterone 20-carbonyl group. Surprisingly, the crystal structure of the hPR ligand binding domain (LBD) in complex with progesterone suggests that the carbonyl oxygen in position 20 (O20) is not involved in hydrogen bond contacts. To investigate these surprising and contradicting results further, we performed a molecular dynamics simulation of the hPR-progesterone complex in an aqueous environment. The simulation revealed hPR-Cys891 as the sole but weak hydrogen bonding partner of progesterone in the D-ring. In contrast to the site-directed mutagenesis data a major role of hPR-Cys891 in progesterone recognition could not be confirmed. Isolated hydrogen bond acceptors, such as the prosterone O20 group, in a relatively lipophilic environment of the receptor led to a decrease in affinity of the ligand. Based on this consideration and the structure of the PR, we designed compounds lacking such an acceptor function. If the X-ray structure and the calculations were right, these compounds should bind with comparable or higher affinity versus that of progesterone. E-17-Halomethylene steroids were synthesized and pharmacologically characterized in vitro and in vivo. Although the compounds are unable to form hydrogen bonds with the hPR in the D-ring region, they bind with superior affinity and exert stronger in vivo progestational effects than progesterone itself. Our investigations have confirmed the results of the X-ray structure and disproved the old pharmacophore model for progestogenic activity, comprising two essential polar functional groups on both ends of the steroid core. The 20-carbonyl group of progesterone is likely to play a role beyond PR-binding, e.g. in the context of other functions via the androgen and mineralocorticoid receptors and as a site of metabolic inactivation.


Steroids | 1999

Nitrile hydratase from Rhodococcus erythropolis: Metabolization of steroidal compounds with a nitrile group

Günter Kaufmann; Horst Dautzenberg; Harry Henkel; Gerd Müller; Thomas Schäfer; Bernd Undeutsch; Michael Oettel

The progestin dienogest (17alpha-cyanomethyl-17beta-hydroxy-estra-4,9-dien-3-one) was metabolized by the nitrile hydratase-containing microorganism Rhodococcus erythropolis. An enzymatic hydrolysis of the nitrile group at the 17alpha-side chain was intended to obtain novel derivatives and to test them for progesterone receptor affinity. In contrast to the rapid enzymatic hydrolysis of nonsteroidal nitriles, the nitrile group of dienogest was cleaved very slowly. The dominant reaction was an aromatization of ring A. After prolonged fermentation, the 17alpha-acetamido derivatives of estradiol and of 9(11)-dehydroestradiol were formed. Three of the metabolites were also prepared synthetically. They were tested for hormonal activity by assessing their binding to progesterone and estrogen receptors in vitro. Neither the aromatized 17alpha-acetamido derivatives nor the dienogest derivative 17alpha-acetamido-17beta-hydroxy-estra-4,9-dien-3-one, which was prepared synthetically only, exhibited affinity for the progesterone receptor.


Seminars in Reproductive Medicine | 2005

Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).

Gerd Schubert; Walter Elger; Günter Kaufmann; Birgitt Schneider; Gudrun Reddersen; Kristof Chwalisz


Archive | 1999

14,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds

Sigfrid Schwarz; Gerd Schubert; Sven Ring; Walter Elger; Birgitt Schneider; Günter Kaufmann; Lothar Sobek


Archive | 1994

Use of steroids with a phenolic a-ring structure for prophylaxis and therapy of radical-mediated cell damage

Peter Droescher; Bernd Menzenbach; Kurt Ponsold; Bernd Undeutsch; Michael Oettel; Wolfgang Römer; Günter Kaufmann; Jens Schroder


Archive | 1998

11 Beta-Benzaldoxim-9 Alpha, 10 Alpha-epoxy-estr-4-en-derivatives, a process for their production and pharmaceutical compositions containing them

Walter Dr Elger; Günter Kaufmann; Sven Ring; Birgitt Schneider; Gerd Schubert


Archive | 1994

Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances

Peter Droescher; Bernd Menzenbach; Kurt Ponsold; Bernd Undeutsch; Michael Oettel; Wolfgang Römer; Günter Kaufmann; Jens Schroder


Archive | 1994

Androgens and anabolic agents

Rolf-Dieter Hesch; Michael Oettel; Peter Droescher; Sigfrid Schwarz; Bernd Menzenbach; Wolfgang Römer; Günter Kaufmann; Jens Schroder


Archive | 2002

17-methylene steroids, process for their production and pharmaceutical compositions that contain these compounds

Bernd Menzenbach; Peter Droescher; Walter Elger; Alexander Hillisch; Günter Kaufmann; Hans-Udo Schweikert; Gerd Müller


Archive | 1999

Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds

Walter Elger; Günter Kaufmann; Sven Ring; Birgitt Schneider; Sigfrid Schwarz; Lothar Sobek

Collaboration


Dive into the Günter Kaufmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sven Ring

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Gerd Schubert

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge